Document x5aYpkXppYQ9Mjz5N1eb0221Q

Message From: Sent: To: CC: Subject: Daguillard, Robert [/0=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=BBE9682B940C4F2C90732E4D37355DD4-DAGUILLARD,] 3/27/2018 3:04:25 PM 1 Press [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=b293283291dc44eOb5dlc36be9281d8a-Press] Subject: MEDIA INQUIRY: Filtering pharmaceuticals out of wastewater Shoshana, for attribution to "an EPA spokesperson," please: On Background: We can offer theses webinars for background information: Pharmaceutical Residues in Municipal Wastewater Concentrations of Prioritized Pharmaceuticals in Effluents from -so Large Wastewater Treatment Plants in the US and Implications for Risk Estimation From: Lynn, Tricia Sent: Tuesday, March 20, 2018 3:54 PM To: Press < Press@epa.gov> Subject: FW: MEDIA INQUIRY: Filtering pharmaceuticals out of wastewater I'll work with OW. From: Shoshana Wodinsky [_______________ E x - _6_______________ j Sent: Tuesday, March 20, 2018 3:11 PM To: Lynn, Tricia <iyrui.trida@ep3.gov> Hello Tricia, My name is Shoshana - I'm a reporter for Scienceline currently working on a story about water filtration - specifically, why it's so difficult to remove pharmaceuticals from water. Please let me know if you could possibly schedule a phone call this week or next, or if you'd prefer to keep the questions emailonly. if there are any other colleagues that you believe could speak to this issue, feel free to forward this email their way. Looking forward to hearing from you. All the best. SW Sierra Club v. E P A 18cv3472 N DCA Tier 13 ED 002061 00018190-00001